Catalog Products » CytoSinct™ CD34 Nanobeads, human (GMP)

CytoSinct™ CD34 Nanobeads, human (GMP)

CytoSinct CD34 Nanobeads, human (GMP) is intended for the in vitro magnetic labeling for pre-separation or other processing of human CD34 positive cells from heterogeneous cell populations, enabling further cultivation and/or genetic modification of the cells.
L00948
$2498.00

Ask us a question
Overview
Product Description CytoSinct CD34 Nanobeads, human (GMP) is intended for the in vitro magnetic labeling for pre-separation or other processing of human CD34 positive cells from heterogeneous cell populations, enabling further cultivation and/or genetic modification of the cells.

Properties
Capacity
Catalog number SizeCapacity
L009487.5 mLUp to 6×108 target cells from up to 6×1010 total cells.
Composition Colloidal solution of iron-dextran nanobeads conjugated to monoclonal CD34 antibody in PBS buffer stabilized with HSA and Poloxamer 188
Endotoxin Content < 2 EU/mL as determined by Limulus Amebocyte Lysate (LAL) limit assay (USP <85>)
Sterility Sterility is tested and confirmed according to USP <71>
Storage & Stability Store at 2-8°C

Regulatory and legal notes

Warnings and precautions
Warnings and precautions 1. Do not freeze.
2. The product is intended for in vitro use only. Not for intravenous infusion.
3. Any clinical application of the separated cells is exclusively within the responsibility of the user.
4. Do not use after the expiry date printed on the product label.
5. Do not use it if the package is damaged. Use reagent only if the vial is undamaged and sealed.
6. Do not reuse.
7. The product is not recommended for use with patients known or suspected to have sensitivity against mouse immunoglobulins or iron-dextran.
8. Patients may develop human anti-mouse antibodies (HAMA).

Instructions for use
Instructions for use 1. Label cells at room temperature for 30 minutes.
2. Work under sterile conditions.
3. The capacity given is for reference. Optimizing the process according to actual requirements is recommended.